ArticleScientific reports2026
Exonisation of an Alu element in the 3'-UTR contributes to SRD5A2 deficiency.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Steroid 5α-reductase deficiency is a rare autosomal recessive condition caused by mutations in the SRD5A2 gene that leads to a severe virilisation deficit of the external genitalia in individuals with a 46,XY karyotype. Here we report an adult 46,XY person with clinically confirmed steroid 5α-reductase deficiency. Sanger sequencing revealed a compound heterozygous, maternal, pathogenic c.692A > G; p.(His231Arg) variant and a very rare paternal c.*66T > G variant in the 3'-UTR. RT-PCR products of individual's derived genital skin fibroblasts revealed that only the maternal variant is expressed while the paternal variant could not be detected. PacBio RNA Isosequencing revealed that the variant c.*66T > G introduces a new strong splice donor site 66 nt after the canonical stop codon that is spliced to an inverted Alu sequence located 15 kb downstream. In all paternal, but none of the maternal transcripts, we found a new exon junction 66 nt after the stop codon within the 3'-UTR. Mammalian transcripts with an intron excision site > 55 nt downstream from a termination codon are subject to degradation by the nonsense-mediated decay (NMD) pathway. We conclude that the pathogenic maternal variant, together with the NMD-triggered downregulation of the paternal allele, is causative for the observed SRD5A2 deficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.